SCGB1A1 and chronic kidney disease: Even higher serum CC16 concentrations were observed in the following groups, with no significant differences among these groups: ARDS+AKI group (64.89 ± 20.47 ng/ml), ARDS+CKD group (72.21 ± 18.63 ng/ml), AKI group (59.77 ± 26.76 ng/ml), and CKD group (62.77 ± 25.11 ng/ml) (Fig. 1).